Johnson & Johnson: Premature Ejaculation trials

The registry lists 12 Premature Ejaculation studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 2 have results posted.

Phase 1 1Phase 3 8No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation TherapyCompletedNCT01063881Phase 3Results posted
• Concomitant Use of PriLigy in Men Treated for Erectile DysfunctionCompletedNCT01063855Phase 3Results posted
• A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking TerazosinCompletedNCT01366664Phase 1
• PRILIGY Usage Patterns in Selected PopulationsCompletedNCT01273545
• An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid EjaculationCompletedNCT01230762Phase 3
• An Observational Study of Men With Premature Ejaculation Who Are Treated With Dapoxetine Hydrochloride or Alternate Care Defined as Any Treatment Other Than Dapoxetine HydrochlorideCompletedNCT01021670
• A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature EjaculationCompletedNCT00229073Phase 3
• A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation.CompletedNCT00211107Phase 3
• A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature EjaculationCompletedNCT00211094Phase 3
• A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature EjaculationCompletedNCT00210704Phase 3
• A Study to Evaluate Intravaginal Ejaculation Time in Men With and Without Premature EjaculationCompletedNCT00210678
• A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature EjaculationCompletedNCT00210613Phase 3